Addressing Unmet Needs in the Management of AML: From Testing to Targeted Therapy

SOHO Highlights: State of the Art and Next Questions
Avatar

State of the Art and Next Questions: AML

By SOHO Highlights: State of the Art and Next Questions FEATURING Farhad Ravandi
By SOHO Highlights: State of the Art and Next Questions FEATURING Farhad Ravandi
377 views
March 25, 2024
Comments 0
Login to view comments. Click here to Login
06:30

EHA 2024 Insights: QuANTUM-First Trial - Newly Diagnosed FLT3-ITD+ A…

Insights from 2024 EHA Annual Meeting

E. Oliva

124 views
23:51

Pre-Transplant Management of High-Risk AML

Vanderbilt University Medical Center (VUMC)

K. Fedorov

88 views
14:58

ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patien…

2024 ASCO® Annual Meeting Insights Hub

C. McMahon

287 views
21:05

ASCO® 2024 Summary: "The Art and Science of Caring for Older Adults …

2024 ASCO® Annual Meeting Insights Hub

K. Poh Loh

96 views
35:08

Experts Discuss the Role of Stem Cell Transplant in AML

MyCancerHaven

R. Vij, M. Qazilbash

112 views
48:04

Integrating Targeted Therapies in AML

Icahn School of Medicine at Mount Sinai

H. Kantarjian

406 views
20:40

What is New in AML: Risk Classification, Germline Mutations, and Tar…

Rush University Medical Center

E. Atallah

216 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

393 views
17:01

R/R AML: Current, Emerging, and Targeted Therapies

Indy Hematology Review

R. Komrokji

344 views
17:51

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Indy Hematology Review

H. Erba

882 views
28:02

2024 Updates in AML

University of Colorado Division of Hematology

C. McMahon

720 views
06:13

FLT3-ITD Mutated AML: PROs From the QuANTUM-First Trial of Quizartin…

Insights from 2023 ASH Annual Meeting

E. Oliva

151 views
29:38

FLT3-Mutated AML: Advances in Frontline Treatment

Scripps Health

N. Short

244 views
07:56

Role of Mutations in AML: FLT3-ITD Mutation Confers Poor Prognosis b…

University of Miami Sylvester Comprehensive Cancer Center

S. Venugopal

183 views
18:27

FLT3-ITD Mutated AML: QuANTUM-First - Safety by Treatment Phase and …

Insights from 2023 ASH Annual Meeting

H. Erba

208 views
22:30

Emerging Treatment Options for AML in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

A. Perl

685 views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views
10:32

FLT3-ITD Mutated AML: Quizartinib, Venetoclax, & Decitabine Triple C…

Insights from 2023 ASH Annual Meeting

M. Yilmaz

140 views